Health Partners International of Canada currently interfaces with all five major sectors of the Canadian health care industry: the research-based companies; the generic companies; the over-the-counter group, NDMAC; the biotech Canada group of companies; as well as the medical devices and medical supply companies. All have indicated support that with such an incentive in place in Canada, which is currently in place in the United States, the volumes of needed specified medical aid would greatly increase in Canada.
Right now--I don't know whether you're aware of this--medical aid donations are treated, from a tax point of view, as if the product has been destroyed, and yet we have companies manufacturing for us. We send product overseas dated 2009, 2010, 2011, and yet the product, which is what you'd find in drug stores here today, is, according to the tax treatments, similar to being destroyed. All sectors have said that if Canada endorses this tax incentive system they will come to the plate.